3D model (JSmol)
|Molar mass||89.05 g·mol−1|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
- Arabinopyranosyl-N-methyl-N-nitrosourea (Aranose)
- Carmustine (BCNU, BiCNU)
- Ethylnitrosourea (ENU)
- Lomustine (CCNU)
- N-Nitroso-N-methylurea (NMU)
- Ranimustine (MCNU)
- Streptozocin (Streptozotocin)
Nitrosourea compounds are DNA alkylating agents and are often used in chemotherapy. They are lipophilic and thus can cross the blood–brain barrier, making them useful in the treatment of brain tumors such as glioblastoma multiforme.
- "Antineop". Archived from the original on 2009-03-07. Retrieved 2009-01-24.
- Takimoto CH, Calvo E. "Principles of oncologic pharmacotherapy". in Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ (Eds) Cancer management: a multidisciplinary approach. 11 ed. 2008.
- Tucci E, Verdiani P, Di Carlo S, Sforza V (1986). "Lomustine (CCNU)-induced pulmonary fibrosis". Tumori. 72 (1): 95–8. PMID 3952821.
- Nitrosourea+Compounds at the US National Library of Medicine Medical Subject Headings (MeSH)
- DDB 9052
|This inorganic compound–related article is a stub. You can help Wikipedia by expanding it.|
|This article about an organic compound is a stub. You can help Wikipedia by expanding it.|